investorscraft@gmail.com

Intrinsic ValueCareCloud, Inc. (CCLDO)

Previous Close$26.13
Intrinsic Value
Upside potential
Previous Close
$26.13

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

CareCloud, Inc. operates in the healthcare technology sector, providing cloud-based solutions for medical practices, hospitals, and health systems. The company’s core revenue model is driven by subscription-based software services, including electronic health records (EHR), practice management, and revenue cycle management (RCM) tools. These offerings streamline clinical workflows, enhance billing efficiency, and improve patient engagement, positioning CareCloud as a key player in the digital transformation of healthcare administration. The company serves a diverse clientele, ranging from small independent practices to larger healthcare networks, leveraging its scalable platform to adapt to varying operational needs. CareCloud competes in a fragmented but rapidly growing market, where demand for integrated, interoperable solutions is rising due to regulatory pressures and the shift toward value-based care. Its competitive edge lies in its user-friendly interfaces, robust analytics, and compliance with evolving healthcare standards, though it faces stiff competition from larger EHR vendors and niche specialists. The company’s ability to innovate and expand its service offerings will be critical in maintaining its market position amid increasing consolidation and technological advancements in the sector.

Revenue Profitability And Efficiency

CareCloud reported revenue of $110.8 million for the period, with net income of $7.9 million, reflecting a turnaround from prior challenges. Diluted EPS stood at -$0.28, indicating lingering profitability pressures. Operating cash flow was robust at $20.6 million, supported by efficient working capital management, while capital expenditures were modest at -$1.7 million, suggesting disciplined investment in growth initiatives.

Earnings Power And Capital Efficiency

The company’s operating cash flow underscores its ability to generate liquidity from core operations, a positive signal for earnings sustainability. However, negative diluted EPS highlights ongoing margin compression, possibly due to competitive pricing or integration costs. Capital efficiency appears stable, with limited capex relative to cash flow, though reinvestment will be crucial to maintain technological competitiveness in the evolving healthcare IT landscape.

Balance Sheet And Financial Health

CareCloud maintains a conservative balance sheet, with $5.1 million in cash and equivalents and total debt of $3.5 million, reflecting low leverage. The net cash position provides flexibility for strategic investments or acquisitions. Shareholders’ equity is supported by retained earnings, though the absence of dividends aligns with the company’s focus on reinvesting profits for growth.

Growth Trends And Dividend Policy

Revenue growth trends are not explicitly provided, but the company’s focus on SaaS-based healthcare solutions aligns with industry tailwinds. CareCloud does not currently pay dividends, prioritizing organic expansion and potential M&A to capture market share. Future growth will hinge on adoption of its platform and cross-selling opportunities within its existing client base.

Valuation And Market Expectations

With a modest market capitalization implied by its share count and financials, CareCloud’s valuation likely reflects its niche position and mixed profitability. Investors may weigh its cash flow generation against sector peers, though the negative EPS could temper near-term optimism. Market expectations likely center on execution in converting revenue growth to sustained profitability.

Strategic Advantages And Outlook

CareCloud’s strategic advantages include its cloud-native platform and focus on mid-market healthcare providers, a segment often underserved by larger competitors. The outlook depends on its ability to scale efficiently, innovate in analytics and interoperability, and navigate regulatory changes. Success in these areas could solidify its position as a consolidator in the fragmented healthcare IT space.

Sources

Company filings (CIK: 0001582982), inferred financials for FY 2024

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount